Bu çeviri hazırlanıyor. Bu süre içinde İngilizce orijinal sürümü gösteriyoruz.
İş dünyası · 10.09.20101 dk okuma
Schmid Laboratories, Inc. et al.; Withdrawal of Approval of Five New Drug Applications
Yerel otomatik çeviri · Kaynağın orijinal dili
Özet
The Food and Drug Administration (FDA) is withdrawing approval of five new drug applications (NDAs) from multiple holders of these applications. The basis for the withdrawals is that the holders of the applications have repeatedly failed to file required annual reports for the applications.
Kaynağın orijinal dili: Federal Register — Health and Human ServicesOrijinal duyuruyu açın →